Baird lowered the firm’s price target on Cardinal Health (CAH) to $248 from $257 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results and raised the 2027 forecast.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health price target lowered to $245 from $249 at Citi
- Cardinal Health Lifts 2026 Outlook After Strong Q3
- Cardinal Health price target lowered to $240 from $260 at BofA
- Cardinal Health raises FY26 EPS view to $10.70-$10.80 from $10.15-$10.35
- Cardinal Health Posts Strong Q3 2026 Non-GAAP Results